# Entero Healthcare Solutions (NSE: ENTERO) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ENTERO · Pivot · prices to 22 Oct 2026

Entero Healthcare Solutions (NSE: ENTERO) closed at ₹1,504.20 on 22 Oct 2026, down 0.19% on the day. With a market capitalisation of ₹6,547 Cr, it ranks 689th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Distribution.

At its last close the stock traded at 57.1× trailing earnings, against a return on equity of 6.8% in FY26. Over the past year the share price has risen 36.0%. Its 52-week range is ₹944.00 (29 Dec 2025) to ₹1,920.00 (7 Sep 2026); the last close is 21.7% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹1,910 Cr (+42.6% year on year) and net profit ₹45 Cr (+43.6%), on a consolidated basis. Promoters held 52.40% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹1,504.20 |
| Market cap | ₹6,547 Cr |
| P/E (trailing) | 57.1 |
| ROE | 6.8% (FY26) |
| ROCE | 12.0% (FY26) |
| Debt to equity | 0.34 |
| 52-week high | ₹1,920.00 (7 Sep 2026) |
| 52-week low | ₹944.00 (29 Dec 2025) |
| 1-year return | +36.0% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹1,910 Cr | +42.6% | ₹45 Cr | +43.6% | ₹6.44 |
| Q3 FY26 | ₹1,707 Cr | +25.6% | ₹34 Cr | +15.0% | ₹6.35 |
| Q2 FY26 | ₹1,571 Cr | +20.8% | ₹37 Cr | +40.6% | ₹7.26 |
| Q1 FY26 | ₹1,404 Cr | +28.0% | ₹30 Cr | +47.2% | ₹6.39 |
| Q4 FY25 | ₹1,339 Cr | +29.5% | ₹31 Cr | +48.3% | ₹5.91 |
| Q3 FY25 | ₹1,359 Cr | +36.9% | ₹29 Cr | +321.9% | ₹5.85 |
| Q2 FY25 | ₹1,301 Cr | +30.6% | ₹26 Cr | +399.6% | ₹5.43 |
| Q1 FY25 | ₹1,097 Cr | +22.0% | ₹21 Cr | +219.3% | ₹4.62 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹5,096 Cr | ₹107 Cr |
| FY24 | ₹3,922 Cr | ₹40 Cr |
| FY23 | ₹3,300 Cr | −₹11 Cr |
| FY22 | ₹2,522 Cr | −₹29 Cr |
| FY21 | ₹1,780 Cr | −₹15 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 52.40%
- Foreign institutions: 4.37%
- Domestic institutions: 15.48%
- Non-institutions: 27.75%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Morepen Laboratories](https://app.pivotnow.in/stock/MOREPENLAB) | ₹125.70 | ₹6,888 Cr | 72.7 | — |
| [Supriya Lifescience](https://app.pivotnow.in/stock/SUPRIYA) | ₹848.80 | ₹6,831 Cr | 32.7 | — |
| [Bliss GVS Pharma](https://app.pivotnow.in/stock/BLISSGVS) | ₹638.00 | ₹6,766 Cr | 53.1 | — |
| [Sanofi India](https://app.pivotnow.in/stock/SANOFI) | ₹2,845.00 | ₹6,552 Cr | 21.2 | — |
| [Kovai Medical Center & Hospital](https://app.pivotnow.in/stock/KOVAI) | ₹5,738.00 | ₹6,279 Cr | 25.7 | — |
| [Nephrocare Health Services](https://app.pivotnow.in/stock/NEPHROPLUS) | ₹599.90 | ₹6,019 Cr | 74.1 | — |

## Questions and answers

### What is the share price of Entero Healthcare Solutions today?

Entero Healthcare Solutions (NSE: ENTERO) last closed at ₹1,504.20 on 22 Oct 2026. Its 52-week high is ₹1,920.00 and its 52-week low is ₹944.00.

### What is the market cap of Entero Healthcare Solutions?

Entero Healthcare Solutions' market capitalisation is ₹6,547 Cr (₹6,547 Cr) at the 22 Oct 2026 close, ranking 689th among the NSE companies Pivot tracks.

### What is the P/E ratio of Entero Healthcare Solutions?

Entero Healthcare Solutions trades at a trailing P/E of 57.1. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 53.1.

### What is the ROE and ROCE of Entero Healthcare Solutions?

Return on equity was 6.8% in FY26 and return on capital employed was 12.0% in FY26 (consolidated figures).

### Is Entero Healthcare Solutions a debt-free company?

No. Entero Healthcare Solutions' debt-to-equity ratio was 0.34 in FY26, with total debt of ₹123 Cr.

### What were Entero Healthcare Solutions' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Entero Healthcare Solutions reported revenue of ₹1,910 Cr, +42.6% year on year, and net profit of ₹45 Cr, +43.6% year on year.

### How has Entero Healthcare Solutions stock performed over the last year?

Entero Healthcare Solutions' share price has risen 36.0% over the past year, +21.2% over three months and −16.4% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Entero Healthcare Solutions?

As of 30 Jun 2026: promoters 52.40%, foreign institutions 4.37%, domestic institutions 15.48%, non-institutions 27.75%.

### Who are Entero Healthcare Solutions' competitors?

The listed Pharma & Healthcare companies closest to Entero Healthcare Solutions by market cap are Morepen Laboratories, Supriya Lifescience, Bliss GVS Pharma, Sanofi India, Kovai Medical Center & Hospital and Nephrocare Health Services.

### Is Entero Healthcare Solutions a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Entero Healthcare Solutions' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ENTERO against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.